Dashboard
Manage Tickers

LGND


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ligands-captisol-technology-powers-new-fda-approved-lasix-onyu-for-at-home-edema-treatment-in-heart-failure-patients
Ligand's Captisol Technology Powers New FD...
10/09/2025 11:16:10

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that its partner SQ Innovation Inc. has received approval fro...

arecor-and-ligand-pharmaceuticals-sign-royalty-and-technology-access-deal-for-at220-and-at292-worth-up-to-11m
Arecor And Ligand Pharmaceuticals Sign Roy...
09/25/2025 06:54:40

Co-development Agreement with US Insulin Pump Device Company for AT278 and Sale of Royalty and Technology Access Fees for up to...

oppenheimer-maintains-outperform-on-ligand-pharmaceuticals-raises-price-target-to-190
Oppenheimer Maintains Outperform on Ligand...
09/03/2025 14:43:19

Oppenheimer analyst Trevor Allred maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperform and raises the price targ...

what-analysts-are-saying-about-ligand-pharmaceuticals-stock
What Analysts Are Saying About Ligand Phar...
09/02/2025 22:01:24

benchmark-maintains-buy-on-ligand-pharmaceuticals-raises-price-target-to-175
Benchmark Maintains Buy on Ligand Pharmace...
09/02/2025 13:44:50

Benchmark analyst Robert Wasserman maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and raises the price target fro...

hc-wainwright--co-maintains-buy-on-ligand-pharmaceuticals-raises-price-target-to-206
HC Wainwright & Co. Maintains Buy on Ligan...
08/28/2025 16:34:15

HC Wainwright & Co. analyst Joseph Pantginis maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and raises the pr...

reported-earlier-ligand-pharmaceuticals-prices-400m-075-convertible-senior-notes-due-2030-in-private-placement-to-qualified-institutional-buyers
Reported Earlier, Ligand Pharmaceuticals P...
08/12/2025 07:28:57

ligand-pharmaceuticals-to-offer-400m-convertible-senior-notes-due-2030-in-a-private-placement
Ligand Pharmaceuticals To Offer $400M Conv...
08/11/2025 11:15:47

rbc-capital-maintains-outperform-on-ligand-pharmaceuticals-raises-price-target-to-185
RBC Capital Maintains Outperform on Ligand...
08/08/2025 18:17:44

RBC Capital analyst Douglas Miehm maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperform and raises the price targ...

ligand-pharmaceuticals-raises-fy2025-adj-eps-guidance-from-600-625-to-670-700-vs-612-est-raises-fy2025-sales-guidance-from-180000m-200000m-to-200000m-225000m-vs-194021m-est
Ligand Pharmaceuticals Raises FY2025 Adj E...
08/07/2025 11:03:18

25 Financial GuidanceLigand is increasing its 2025 full year financial guidance. The Company now expects total revenue of $200 ...

ligand-pharmaceuticals-q2-adj-eps-160-beats-142-estimate-sales-47627m-beat-43870m-estimate
Ligand Pharmaceuticals Q2 Adj. EPS $1.60 B...
08/07/2025 11:02:32

Ligand Pharmaceuticals (NASDAQ:LGND) reported quarterly earnings of $1.60 per share which beat the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Core News & Articles
Orchestra BioMed Secures $111M From Medtro...
08/05/2025 11:14:13

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company"))), a biomedical company acce...

Core News & Articles
Orchestra BioMed Secures $70M In New Capi...
07/31/2025 20:39:10

oppenheimer-maintains-outperform-on-ligand-pharmaceuticals-raises-price-target-to-162
Oppenheimer Maintains Outperform on Ligand...
07/30/2025 13:39:19

Oppenheimer analyst Trevor Allred maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperform and raises the price targ...

pelthos-therapeutics-launches-first-at-home-prescription-gel-for-highly-contagious-skin-disease
Pelthos Therapeutics Launches First At-Hom...
07/10/2025 12:13:33

Pelthos launches Zelsuvmi, the first FDA-approved at-home prescription gel for molluscum, shown to clear lesions in as little a...

Core News & Articles
Ligand Pharm's Partner Pelthos Therapeutic...
07/10/2025 12:09:22

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that its partner Pelthos Therapeutics Inc. (NYSE:PTHS) has co...

verona-pharma-rhythm-pharmaceuticals-aes-and-other-big-stocks-moving-higher-on-wednesday
Verona Pharma, Rhythm Pharmaceuticals, AES...
07/09/2025 15:06:14

Core News & Articles
Reported July 3, 2025: Pelthos Therapeutic...
07/07/2025 15:06:59

- SEC Filing

oppenheimer-maintains-outperform-on-ligand-pharmaceuticals-raises-price-target-to-145
Oppenheimer Maintains Outperform on Ligand...
05/09/2025 17:33:49

Oppenheimer analyst Trevor Allred maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperform and raises the price targ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION